Phase II trial of preoperative chemoradiotherapy using intensity-modulated radiotherapy for locally advanced rectal cancer
Not Applicable
Recruiting
- Conditions
- ocally advanced rectal cancer
- Registration Number
- JPRN-UMIN000048760
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1) Uncontrollable comorbidity (diarrhea, interstitial pneumonia, collagen vascular disease,diabetes mellitus, heart failure etc) 2) Pregnant or child-bearing potential, lactating patients 3) History of hypersensitivity to capecitabine or 5-fluorouracil 4) Currently taking tegafur/Gimeracil/Oteracil or within 7 days after discontinuation 5) Considered to be difficult to participate the current trial from psychotic disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method